Lero bungwe la Bill & Melinda Gates Foundation ndi Wellcome aliyense alonjeza US $ 150 miliyoni pa ndalama zokwana $300 miliyoni ku Coalition for Epidemic Preparedness Innovations (CEPI), mgwirizano wapadziko lonse womwe unakhazikitsidwa zaka zisanu zapitazo sabata ino ndi maboma a Norway ndi India, Gates Foundation, Wellcome, ndi World Economic Forum. Malonjezowa akubwera msonkhano wapadziko lonse wobwezeretsanso mu Marichi kuti uthandizire dongosolo lazaka zisanu la CEPI lokonzekera bwino, kupewa, komanso kuyankha moyenera miliri ndi miliri yamtsogolo.

Kuyambira pomwe idakhazikitsidwa, CEPI yatenga gawo lalikulu lasayansi pothana ndi miliri padziko lonse lapansi, kuyang'anira zochitika zingapo zasayansi ndikuyika kukonzekera miliri pakati pazantchito zapadziko lonse lapansi za R&D. Mliri wa COVID-19 utayamba, CEPI idayankha nthawi yomweyo, ndikumanga imodzi mwamagawo akulu kwambiri padziko lonse lapansi komanso osiyanasiyana omwe akufuna kulandira katemera wa COVID-19 - 14 onse, kuphatikiza asanu ndi mmodzi omwe akupitilizabe kulandira ndalama, ndipo atatu mwa iwo apatsidwa mwayi wadzidzidzi. kugwiritsa ntchito mndandanda wa World Health Organisation (WHO).

CEPI idachita ndalama zoyambilira popanga katemera wa Oxford-AstraZeneca COVID-19, yemwe pano akupulumutsa miyoyo padziko lonse lapansi. Mwezi watha, katemera wa Novavax wa COVID-19 wopangidwa ndi mapuloteni - wothandizidwa kwambiri ndi CEPI - adalandira mndandanda wazomwe zimagwiritsidwa ntchito mwadzidzidzi ndi WHO ndipo ali wokonzeka kuthandiza kuyesetsa kuthana ndi mliriwu padziko lonse lapansi. Mlingo wopitilira 1 biliyoni wa katemera wa Novavax tsopano ukupezeka ku COVAX, ntchito yapadziko lonse lapansi yoyendetsedwa ndi CEPI yomwe ikufuna kupereka mwayi wopeza katemera wa COVID-19. CEPI ikupitilizabe kugwira ntchito pa katemera wam'badwo wotsatira wa COVID-19, kuphatikiza katemera wa "umboni wosiyanasiyana" wa COVID-19 ndi kuwombera komwe kumatha kuteteza ku ma coronavirus onse, ndikuchotsa chiwopsezo cha miliri yamtsogolo ya coronavirus.

Kupitilira COVID-19, CEPI yadzaza mpata wofunikira pothandizira katemera wa katemera pambali pa R&D. CEPI pakadali pano ikuthandizira kafukufuku ndi chitukuko cha katemera wopezeka ku matenda ena opatsirana, kuphatikiza katemera woyamba kufikira mayeso azachipatala motsutsana ndi ma virus akupha a Nipah ndi Lassa. Bungweli lachitanso gawo lalikulu poyesa kuthetsa Ebola, kuphatikizapo kuthandizira chitukuko cha katemera wachiwiri wa Ebola ndi Janssen. Kuphatikiza pa kupititsa patsogolo chitukuko cha katemera wa katemera ndi njira zatsopano za katemera, CEPI ikuyang'ana kwambiri kuchepetsa nthawi yomwe imatengera kupanga katemera wopulumutsa moyo motsutsana ndi chiwopsezo chilichonse cha ma virus (otchedwa "Disease X") - mpaka masiku 100 kuchokera ku tizilombo toyambitsa matenda. kutsatizana. Izi zikuyimira kuphatikizika kwa sikelo ndi liwiro lomwe lingapulumutse mamiliyoni a miyoyo ndi ma thililiyoni a madola.

Mliriwu wachulukitsanso mafunde padziko lonse lapansi, ndikuwonetsa gawo lofunikira la mabungwe apadziko lonse lapansi monga CEPI omwe amayika mwayi wofanana pachimake pa ntchito yawo. Zambiri zaposachedwa zaku Northeastern University zikuwonetsa kuti kupezeka kwa katemera m'maiko opeza ndalama zochepa ngati Kenya kunali kofanana ndi komwe kumayiko opeza ndalama zambiri ngati UK kapena US, 70 peresenti yakufa kwa COVID-19 mpaka pano akadapewedwa.

United Kingdom ikhala ndi msonkhano wokonzanso wa CEPI pa Marichi 8, 2022, ku London. Chochitika chopeza ndalama chidzayitanira maboma, opereka chithandizo kwachifundo, ndi othandizira ena kuti athandizire dongosolo lazaka zisanu la CEPI lothana ndi chiwopsezo cha miliri ndi miliri, zomwe zitha kulepheretsa kufa kwa mamiliyoni ndi ma thililiyoni a madola pakuwonongeka kwachuma.

ZOMWE MUNGACHITE PA NKHANIYI:

When the COVID-19 pandemic began, CEPI responded immediately, building one of the world’s largest and most diverse portfolios of COVID-19 vaccine candidates—14 in all, including six of which continue to receive funding, and three of which have been granted emergency use listing by the World Health Organization (WHO).
In addition to advancing the science underlying vaccine development and new vaccine platforms, CEPI is focused on dramatically reducing the time it takes to develop lifesaving vaccines against any new viral threat (referred to as “Disease X”)—to within 100 days of a pathogen being sequenced.
Since its inception, CEPI has played a central scientific role in curbing epidemics around the world, overseeing a number of scientific breakthroughs and putting pandemic preparedness at the center of the global health R&D agenda.